Global prescription drugs market to reach $2.26t by 2034

The Asia Pacific region is projected to register the fastest growth rate.

The global prescription drugs market is forecast to grow to $2.26t by 2034, according to a study by Polaris Market Research.

The market is currently expanding at a compound annual growth rate of 6.94%, driven by a shift toward personalised medicine and the integration of digital health technologies in drug development.

In 2024, the Alzheimer’s segment generated the highest revenue attributed to the prevalence of cognitive decline in ageing populations. Other key segments analysed include Parkinson’s, Migraine, Chronic Pain, Sleep Disorders, and Major Depressive Disorder.

North America led the global market in 2024 with a 49.57% share, supported by an advanced healthcare infrastructure, high adoption rates for novel therapies, and significant investments.

Meanwhile, the Asia Pacific region is projected to register the fastest growth rate through 2034. Growth in this region is propelled by increased healthcare spending, a rising middle class, and improved access to regulated medications.